LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Newly Reengineered Line of Inverted Microscope Systems to Be Unveiled

By LabMedica International staff writers
Posted on 23 Jul 2012
A newly reengineered line of highly customizable inverted microscope systems will become available for biotech and life science researchers beginning in the fall of 2012.

The well-known microscope manufacturer Olympus (Hamburg, Germany) plans to unveil the new IX3 line of inverted research microscopes at the European Microscopy Congress (EMC) 2012, which is to be held in Manchester, United Kingdom from September 16-21. This event was selected as being especially appropriate, since EMC - which is held once every four years - is Europe's largest exhibition dedicated to microscopy.

Image: The IX3 line of inverted research microscopes (Photo courtesy of Olympus).
Image: The IX3 line of inverted research microscopes (Photo courtesy of Olympus).

Olympus states that the new IX3 systems will offer enhanced precision, stability, and optical performance to meet the most challenging quantitative measurement applications, along with user friendliness, speed, accuracy, and rugged reliability. The company will be hosting several breakout workshops at EMC 2012, where Olympus’ experts will discuss the range of applications offered by the new systems.

IX3 systems will be available for purchase in Europe starting from September 2012.

Related Links:
Olympus



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Hematology Consumables
Bioblood Devices

Latest BioResearch News

Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
23 Jul 2012  |   BioResearch

Genetic Cause Identified for Severe Infant Epilepsy
23 Jul 2012  |   BioResearch

Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
23 Jul 2012  |   BioResearch



INTEGRA BIOSCIENCES AG